C. Rosenfeld

发表

Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease

B. Stockwell, H. Bayır, S. Dixon, 2017, Cell.

Is Myelodysplastic Related Acute Myelogenous Leukemia a Distinct Entity from de novo Acute Myelogenous Leukemia? Potential for Targeted Therapies

H. Kantarjian, C. Rosenfeld, H. Kantarjian, 2001, Leukemia & lymphoma.

WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies

A. Gaiger, M. Cheever, C. Rosenfeld, 2003, Leukemia.

Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial

K. Cornetta, B. Burtness, D. Krause, 2000, Bone Marrow Transplantation.

Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia.

J. Singer, J. Nemunaitis, F. Appelbaum, 1994, Blood.

c‐kit ligand augments granulocyte‐macrophage colony growth from patients with 5q‐ syndrome

J. Nemunaitis, R. Shadduck, C. Rosenfeld, 1993, Stem cells.

A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies

C. Rosenfeld, A. List, Alan F. List, 2000, Leukemia.

Pilot study of recombinant human soluble tumor necrosis factor receptor (TNFR:Fc) in patients with low risk myelodysplastic syndrome.

C. Rosenfeld, C. Bedell, Cindi Bedell, 2002, Leukemia research.

Clinical benefit and survival endpoints from a phase III trial comparing decitabine (DAC) vs supportive care (SC) in patients with advanced myelodysplastic syndromes (MDS)

J. Issa, J. Dipersio, H. Kantarjian, 2005 .

Phase II study of roquinimex in myelodysplastic syndrome.

B. Nilsson, R. Shadduck, C. Rosenfeld, 1997, American journal of clinical oncology.

Antileukemic activity of phenylalanine methyl ester (PME): A lysosomotropic peptide methyl ester

C. Rosenfeld, 1994, Stem cells.

First Report of the Phase III North American Trial of Decitabine in Advanced Myelodysplastic Syndrome (MDS).

J. Issa, J. Dipersio, H. Kantarjian, 2004 .

Resolution of transfusion dependence by recombinant human erythropoietin (rHuEPO) in acquired pure red cell aplasia (PRCA) associated with myeloid metaplasia

R. Shadduck, C. Rosenfeld, Z. Zeigler, 1993, British journal of haematology.

Clinical development of decitabine as a prototype for an epigenetic drug program.

C. Rosenfeld, 2005, Seminars in oncology.

Bone marrow transplant-associated thrombotic microangiopathy: a case series.

J. Nemunaitis, D. Andrews, R. Shadduck, 1995, Bone marrow transplantation.

Successful treatment of T‐γ lymphoproliferative disease with human‐recombinant granulocyte colony stimulating factor

R. Shadduck, C. Rosenfeld, Z. Zeigler, 1992, American journal of hematology.

Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow for acute lymphoblastic leukemia.

R. Shadduck, C. Rosenfeld, O. Colvin, 1991, Medical and pediatric oncology.

Large-scale preparation of adherent lymphokine-activated killer (A-LAK) cells for adoptive immunotherapy in man

T. Whiteside, R. Melder, R. Herberman, 2004, Cancer Immunology, Immunotherapy.

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.

K. Cornetta, D. Blaise, M. Shlomchik, 1998, British Journal of Cancer.

P-119 Advanced myelodysplastic syndromes (MDS): Patient subset results of a phase III trial comparing decitabine (DAC) vs. supportive care (SC)

J. Issa, J. Dipersio, H. Kantarjian, 2005 .

Recombinant human erythropoietin (rhuepo) for treatment of myelodysplastic syndrome

R. Shadduck, C. Rosenfeld, Z. Zeigler, 1993, Stem cells.

Transforming growth factor‐β1 augments macrophage‐colony stimulating factor activity on human marrow

C. Rosenfeld, 1994, Stem cells.

Leading Edge Primer Ferroptosis : A Regulated Cell Death Nexus Linking Metabolism , Redox Biology , and Disease

B. Stockwell, H. Bayır, S. Dixon, 2017 .

Fluconazole Prophylaxis of Fungal Infections in Patients with Acute Leukemia: Results of a Randomized Placebo-Controlled, Double-Blind, Multicenter Trial

H. Horowitz, R. Shadduck, C. Rosenfeld, 1993, Annals of Internal Medicine.

Prevention of Legionella Infections in a Bone Marrow Transplant Unit: Multifaceted Approach to Decontamination of a Water System

U. Matulonis, R. Shadduck, C. Rosenfeld, 1993, Infection Control & Hospital Epidemiology.

hematopoietic malignancies -deoxycytidine (decitabine) in ' hypomethylating agent 5-aza-2 Phase 1 study of low-dose prolonged exposure schedules of the

J. Issa, Rajan Mannari, H. Kantarjian, 2013 .

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies.

Jorge Cortes, Guillermo Garcia-Manero, Francis J Giles, 2004, Blood.

Decitabine improves patient outcomes in myelodysplastic syndromes

John M Bennett, J. Issa, Lanlan Shen, 2006, Cancer.

The kinetics of cyclosporine and its metabolites in bone marrow transplant patients.

C. P. Wang, R. Venkataramanan, R. Shadduck, 1991, British journal of clinical pharmacology.

Increased macrophage colony-stimulating factor levels in immune thrombocytopenic purpura.

J. Nemunaitis, R. Shadduck, C. Rosenfeld, 1993, Blood.

Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for acute nonlymphocytic leukemia in late remission or early relapse.

R. Shadduck, C. Rosenfeld, D. Przepiorka, 1989, Blood.

Intravenous gamma globulin decreases platelet‐associated IgG and improves transfusion responses in platelet refractory states

J. Kiss, R. Shadduck, C. Rosenfeld, 1991, American journal of hematology.

High-dose intravenous gamma globulin improves responses to single-donor platelets in patients refractory to platelet transfusion.

R. Shadduck, C. Rosenfeld, Z. Zeigler, 1987, Blood.

Disposition of total and unbound etoposide following high-dose therapy

C. Stewart, R. Fleming, R. Shadduck, 2004, Cancer Chemotherapy and Pharmacology.

Transfusion of bone marrow red cells during bone marrow harvests.

R. Shadduck, C. Rosenfeld, R. Bryan, 1988, Experimental Hematology.

Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6.

D. Andrews, R. Shadduck, C. Rosenfeld, 1995, Experimental hematology.

Autologous bone marrow transplantation following high-dose busulfan and VP-16 for advanced non-Hodgkin's lymphoma and Hodgkin's disease.

R. Shadduck, C. Rosenfeld, D. Przepiorka, 1991, Experimental hematology.

In vitro evidence for disappearance of erythroid progenitor T suppressor cells following allogeneic bone marrow transplantation for severe aplastic anemia.

R. Shadduck, C. Rosenfeld, K. Mangan, 1988, Blood.

Use of granulocyte-macrophage colony-stimulating factor in patients with malignancy and bone marrow failure.

R. Shadduck, C. Rosenfeld, R. Stoller, 1990, International journal of cell cloning.

Preparation of a monoclonal antibody directed against the receptor for murine colony-stimulating factor-1.

A. Waheed, R. Shadduck, C. Rosenfeld, 1993, Experimental hematology.

Opportunities for Trisenox® (arsenic trioxide) in the treatment of myelodysplastic syndromes

P. Greenberg, J. Dipersio, N. Vey, 2003, Leukemia.

Cyclosporine and methylprednisolone after allogeneic marrow transplantation: association between low cyclosporine concentration and risk of acute graft-versus-host disease.

R. Venkataramanan, R. Shadduck, C. Rosenfeld, 1991, Bone marrow transplantation.

High‐dose cytosine arabinoside and L‐asparaginase therapy for poor‐risk adult acute nonlymphocytic leukemia. A retrospective study

R. Shadduck, C. Rosenfeld, A. Winkelstein, 1990, Cancer.

High-dose cyclosporine and corticosteroids for prophylaxis of acute and chronic graft-versus-host disease.

R. Shadduck, C. Rosenfeld, J. Wilson, 1995, Bone marrow transplantation.

Prevention of Legionella infections in a bone marrow transplant unit: multifaceted approach to decontamination of a water system.

U. Matulonis, R. Shadduck, C. Rosenfeld, 1993 .

Reduction of allogeneic transplant morbidity by combining peripheral blood and bone marrow progenitor cells.

J. Nemunaitis, R. Shadduck, C. Rosenfeld, 1993, Leukemia & lymphoma.

Complications of indwelling central venous catheters in bone marrow transplant recipients.

T. Julian, R. Shadduck, C. Rosenfeld, 1991, Surgery, gynecology & obstetrics.

Decitabine: development of a DNA methyltransferase inhibitor for hematological malignancies.

C. Rosenfeld, J. Lyons, M. Mccullar, 2003, Current opinion in investigational drugs.

Pentoxifylline and Ciprofloxacin in Patients with Myelodysplastic Syndrome: A Phase II Trial

J. Nemunaitis, W. Meyer, R. Shadduck, 1995, American journal of clinical oncology.

Diethylstilbestrol-associated hemolytic anemia with a positive direct antiglobulin test result.

C. Rosenfeld, S. Winters, H. Tedrow, 1989, The American journal of medicine.

Treatment of ganciclovir-induced neutropenia with recombinant human GM-CSF.

R. Shadduck, C. Rosenfeld, D. Przepiorka, 1991, The American journal of medicine.

Effectiveness of cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura

G. Obrador, R. Shadduck, C. Rosenfeld, 1993, American journal of hematology.

Eosinophilia resulting from administration of recombinant granulocyte‐macrophage colony‐stimulating factor (rhGM‐CSF) in a patient with T‐γ lymphoproliferative disease

C. Rosenfeld, A. Winkelstein, C. Rosenfeld, 1991, American journal of hematology.

Isolated cardiac aspergillosis after bone marrow transplantation.

C. Rosenfeld, E. Wing, T. R. Miller, 1987, Archives of internal medicine.